Oncology Institute(The) Target Price

Analysts' average 12-month price target for Oncology Institute(The) is $8.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.13

Average Target Price

$8.50

65.7% upside

4 analysts in the last 4 months

High: $10 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-09	BTIG	$9	75.4% upside
2026-07-06	Lake Street	$10	94.9% upside
2026-06-17	Needham	$7	36.5% upside
2026-06-08	BTIGDavid Larsen	$8	55.9% upside
2025-11-25	NeedhamMatthew Shea	$5	2.5% downside
2022-11-11	Guggenheim	$6	17% upside
2022-08-15	Jefferies	$10	94.9% upside

Oncology Institute(The) (TOI) FAQ

Oncology Institute(The)'s target price stands at $8.5. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $8.5 for TOI implies 65.7% upside versus today's price ($5.13). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Oncology Institute(The)'s target price evolved across reporting periods, while the comparison chart places TOI next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.